Complete Filing Data
HCM III ACQUISITION CORP. reported Stockholders Equity of -$12.79 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean HCM III ACQUISITION CORP. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Net Income Loss | $390.4K | -$47.5K |
| Operating Income Loss | -$135.3K | -$47.5K |
| General And Administrative Expense | $135.3K | $47.5K |
| Nonoperating Income Expense | $525.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$12.8M |
| Retained Earnings Accumulated Deficit | -$12.8M |
| Liabilities And Stockholders Equity | $258.4M |
| Liabilities | $13.9M |
| Interest Earned On Marketable Securities Held In Bank Account | |
| Deferred Offering Costs Paid Through Promissory Note Related Party | |
| Assets | $258.4M |
| Accrued Offering Costs | $75.0K |
| Temporary Equity Accretion To Redemption Value | |
| Other Liabilities Noncurrent | $1.2M |
| Marketable Securities Noncurrent | $257.3M |
| Liabilities Current | $664.8K |
| Deferred Underwriting Fee Payable Noncurrent | $12.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0M |
| Assets Current | $1.1M |
| Accrued Liabilities Current | $589.8K |
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | |
| Deferred Costs Current | |
| Accrued Liabilities Current And Noncurrent |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Stockholders Equity | -$12.1M | -$22.5K | $0.00 |
| Retained Earnings Accumulated Deficit | -$12.1M | -$47.5K | |
| Liabilities And Stockholders Equity | $256.0M | $417.7K | |
| Liabilities | $13.4M | $440.2K | |
| Interest Earned On Marketable Securities Held In Bank Account | $3.0K | ||
| Deferred Offering Costs Paid Through Promissory Note Related Party | $171.6K | ||
| Assets | $256.0M | $417.7K | |
| Accrued Offering Costs | $75.0K | $201.1K | |
| Temporary Equity Accretion To Redemption Value | $21.7M | ||
| Other Liabilities Noncurrent | $1.2M | ||
| Marketable Securities Noncurrent | $254.7M | ||
| Liabilities Current | $114.9K | ||
| Deferred Underwriting Fee Payable Noncurrent | $12.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1M | ||
| Assets Current | $1.2M | ||
| Accrued Liabilities Current | $39.9K | ||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 25.0K | ||
| Deferred Costs Current | $397.7K | ||
| Accrued Liabilities Current And Noncurrent | $11.3K |
Cash Flow Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 |
|---|---|
| Increase Decrease In Accrued Liabilities | $11.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Preferred Stock Shares Authorized | 1.1M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | |
| Weighted Average Number Of Shares Outstanding Basic | |
| Weighted Average Number Of Diluted Shares Outstanding | |
| Earnings Per Share Diluted | |
| Earnings Per Share Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Preferred Stock Shares Authorized | 1.1M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 4.3M | |
| Weighted Average Number Of Shares Outstanding Basic | 7.3M | |
| Weighted Average Number Of Diluted Shares Outstanding | 7.3M | |
| Earnings Per Share Diluted | $-0.01 | |
| Earnings Per Share Basic | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Issued During Period Value New Issues | |
| Professional Fees | |
| Prepaid Expense Current | $8.3K |
| Payment Of Expenses Through Promissory Note Related Party | |
| Noninterest Expense Offering Cost | |
| Investment Income Interest | |
| Advisory Fee Reimbursable Income | |
| Prepaid Insurances | $65.0K |
| Prepaid Expense Noncurrent | $37.9K |
| Adjustments To Additional Paid In Capital Warrant Issued | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | |
| Adjustments To Additional Paid In Capital Sale Of Private Placement Warrants | |
| Prepaid Expenses Paid Through Promissory Note Related Party | |
| Additional Paid In Capital |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stock Issued During Period Value New Issues | $25.0K | |
| Professional Fees | $1.6M | |
| Prepaid Expense Current | $34.2K | $20.0K |
| Payment Of Expenses Through Promissory Note Related Party | -$36.2K | |
| Noninterest Expense Offering Cost | $201.1K | |
| Investment Income Interest | $1.7M | |
| Advisory Fee Reimbursable Income | $440.0K | |
| Prepaid Insurances | $65.0K | |
| Prepaid Expense Noncurrent | $54.2K | |
| Adjustments To Additional Paid In Capital Warrant Issued | $3.1M | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $224.3K | |
| Adjustments To Additional Paid In Capital Sale Of Private Placement Warrants | $6.4M | |
| Prepaid Expenses Paid Through Promissory Note Related Party | $20.0K | |
| Additional Paid In Capital | $24.2K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.